ifosfamide has been researched along with Hypophosphatemia in 5 studies
Hypophosphatemia: A condition of an abnormally low level of PHOSPHATES in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Nephrotoxicity is a known side effect of several treatments, including cisplatin, carboplatin, ifosfamide, radiotherapy and nephrectomy, and can cause glomerular filtration rate (GFR) impairment, proteinuria, tubulopathy, and hypertension." | 5.01 | Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer. ( Bökenkamp, A; Kooijmans, EC; Tettero, JM; Tjahjadi, NS; van der Pal, HJ; van Dulmen-den Broeder, E; Veening, MA, 2019) |
| " Nephrotoxicity is one of these known (acute) side effects of several treatments, including cisplatin, carboplatin, ifosfamide, radiotherapy and nephrectomy, and can cause glomerular filtration rate impairment, proteinuria, tubulopathy and hypertension." | 4.89 | Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer. ( Blufpand, H; Bökenkamp, A; Jaspers, MW; Knijnenburg, SL; Kremer, LC; Mulder, RL; Schouten-Van Meeteren, AY; van Dulmen-den Broeder, E; Veening, MA, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krupadev, V | 1 |
| Thomas, V | 1 |
| Dahr, SE | 1 |
| Warrier, R | 1 |
| Kooijmans, EC | 1 |
| Bökenkamp, A | 2 |
| Tjahjadi, NS | 1 |
| Tettero, JM | 1 |
| van Dulmen-den Broeder, E | 2 |
| van der Pal, HJ | 1 |
| Veening, MA | 2 |
| Knijnenburg, SL | 1 |
| Mulder, RL | 1 |
| Schouten-Van Meeteren, AY | 1 |
| Blufpand, H | 1 |
| Kremer, LC | 1 |
| Jaspers, MW | 1 |
| Stöhr, W | 1 |
| Paulides, M | 1 |
| Bielack, S | 1 |
| Jürgens, H | 1 |
| Treuner, J | 1 |
| Rossi, R | 1 |
| Langer, T | 1 |
| Beck, JD | 1 |
| Ashraf, MS | 1 |
| Skinner, R | 1 |
| English, MW | 1 |
| Craft, AW | 1 |
| Pearson, AD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Oral Supplementation With Magnesium to Reduce Febrile Neutropenia in Pediatric Oncology Patients Treated With Cisplatin-Based Chemotherapy: Randomized Clinical Trial[NCT03449693] | Phase 2 | 214 participants (Anticipated) | Interventional | 2017-10-19 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for ifosfamide and Hypophosphatemia
| Article | Year |
|---|---|
Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.
Topics: Adult; Antineoplastic Agents; Carboplatin; Child; Cisplatin; Glomerular Filtration Rate; Humans; Hyp | 2019 |
Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer.
Topics: Adult; Antineoplastic Agents; Carboplatin; Child; Cisplatin; Glomerular Filtration Rate; Humans; Hyp | 2013 |
3 other studies available for ifosfamide and Hypophosphatemia
| Article | Year |
|---|---|
Developmental Delay and Refusal to Walk in an Infant.
Topics: Antineoplastic Agents, Alkylating; Child, Preschool; Developmental Disabilities; Diagnosis, Differen | 2021 |
Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System.
Topics: Abdomen; Adolescent; Age Factors; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemoth | 2007 |
Late reversibility of chronic ifosfamide-associated nephrotoxicity in a child.
Topics: Antineoplastic Agents, Alkylating; Child, Preschool; Chronic Disease; Fanconi Syndrome; Glomerular F | 1997 |